Not applicableNo Longer AvailableNCT05683548What this trial is testingReplicor Compassionate Access ProgramWho this might be right forViral Hepatitis BViral Hepatitis DCirrhosis, Liver+4 more Replicor Inc.
Post-approval studies (Phase 4)UnknownNCT00117533What this trial is testingPegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaWho this might be right forChronic Hepatitis BChronic Hepatitis D National Taiwan University Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06907290What this trial is testingA Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionWho this might be right forChronic Hepatitis D Infection Mirum Pharmaceuticals, Inc. 150
Post-approval studies (Phase 4)Ended earlyNCT01264094What this trial is testingEvaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodWho this might be right forChronic Hepatitis B Bukwang Pharmaceutical 200
Large-scale testing (Phase 3)Looking for participantsNCT07454837What this trial is testingStudy to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving BulevirtideWho this might be right forChronic Hepatitis D Mirum Pharmaceuticals, Inc. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06903338What this trial is testingEvaluate Tobevibart + Elebsiran in Chronic HDV InfectionWho this might be right forViral Hepatitis Vir Biotechnology, Inc. 124
Large-scale testing (Phase 3)Looking for participantsNCT07200908What this trial is testingA Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)Who this might be right forChronic Hepatitis D Infection Mirum Pharmaceuticals, Inc. 172
Large-scale testing (Phase 3)Active Not RecruitingNCT07128550What this trial is testingEvaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideWho this might be right forViral Hepatitis Vir Biotechnology, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02577029What this trial is testingStudy of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)Who this might be right forHepatitis BHepatitis D Arrowhead Pharmaceuticals 79
Not applicableLooking for participantsNCT04166266What this trial is testingNational Cohort of Patients Co-infected With Hepatitis B and Delta VirusesWho this might be right forHepatitis D, ChronicHepatitis B, Chronic ANRS, Emerging Infectious Diseases 800
Not applicableStudy completedNCT07116044What this trial is testingAssessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus InfectionWho this might be right forEvaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients University of Molise 160
Not applicableUnknownNCT04170452What this trial is testingStudy the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis DeltaWho this might be right forChronic Hepatitis DeltaLiver Biopsy Tokhirbek Dolimov 30
Not applicableStudy completedNCT01107483What this trial is testingObserve Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B, Chronic Sun Yat-sen University 140
Early research (Phase 1)Looking for participantsNCT07610772What this trial is testingSafety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D InfectionWho this might be right forHepatitis D, ChronicHepatitis B Chronic Infection Aarhus University Hospital 15
Large-scale testing (Phase 3)Study completedNCT05229991What this trial is testingOnce Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus InfectionWho this might be right forHepatitis D, Chronic Soroka University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00001457What this trial is testingLamivudine for Chronic Hepatitis BWho this might be right forChronic Hepatitis BChronic Hepatitis DGlomerulonephritis+1 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Not applicableLooking for participantsNCT06638320What this trial is testingHepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus InfectionWho this might be right forHepatitis Delta With Hepatitis B Carrier StateChronic Hepatitis b Tam Anh Research Institute 2,452
Not applicableStudy completedNCT03158818What this trial is testingChronic Hepatitis B Virus Infection in ZambiaWho this might be right forHBVFibrosis, LiverCirrhosis, Liver+3 more University of Alabama at Birmingham 326
Testing effectiveness (Phase 2)Study completedNCT03546621What this trial is testingA Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DWho this might be right forChronic Hepatitis D Infection With Hepatitis B Hepatera Ltd. 120
Early research (Phase 1)Study completedNCT04638439What this trial is testingThe Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D InfectionWho this might be right forChronic Hepatitis B InfectionChronic Hepatitis D Infection PharmaEssentia 20